Collagen Mutation Database (CMD)

Collagen Mutation Database (CMD) catalogs sequence variation data linked to patient phenotypes for collagen-related genes to support genetic research and clinical and diagnostic interpretation.

Key Features:

• Locus-specific database (LSDB): CMD implements an LSDB structure for gene-specific variant curation and storage.
• HGVS compliance: Variant descriptions adhere to Human Genome Variation Society (HGVS) recommendations to ensure standardized reporting.
• Multi-gene variant storage: CMD stores sequence variants across multiple genes for individual patients, accommodating complex genetic profiles.
• Data structure optimization: Patient information and sequence variant data are stored in separate, dynamically linked tables to minimize redundancy.
• Customization options: Database schema supports adding custom columns to capture study- or project-specific fields.
• High-throughput sequencing support: CMD accepts sequence variants generated by high-throughput sequencing technologies and has been applied to datasets such as X-chromosomal Mental Retardation.
• Security measures: The system includes protocols to protect against unauthorized access and to maintain confidentiality and data integrity.
• Interoperability and standardization: CMD promotes LSDB standardization to enhance database interoperability and data sharing.

Scientific Applications:

• Genetic research: CMD provides a centralized repository for analyzing collagen gene variation across cohorts.
• Clinical diagnostics: CMD supports clinical interpretation of collagen gene variants for diagnostic reporting.
• Personalized medicine: CMD enables integration of patient-specific variant profiles to inform individualized care considerations.
• Genotype–phenotype correlation: CMD facilitates study of associations between collagen variants and patient phenotypes.
• Inheritance pattern analysis: CMD supports tracking inheritance and familial variant segregation.
• Novel variant discovery: CMD aids identification and cataloging of novel collagen-associated variants linked to disease.
• Large-scale genomic studies: CMD supports aggregation and analysis of high-throughput sequencing datasets for population- or disease-focused studies.

Methodology:

Systematic collection, organization, and linkage of genetic variant data across multiple genes with patient information and sequence variant data stored in separate, dynamically linked tables to enable rapid querying and efficient data retrieval; supports integration of variants from high-throughput sequencing.